RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Pittsburgh, PA · +45 more sites
Prostate Cancer clinical trials in Pittsburgh, PA
17 recruiting prostate cancer studies with a site in Pittsburgh, PA.
RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Pittsburgh, PA · +27 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Chambersburg, PA · Danville, PA · Ephrata, PA · +331 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Philadelphia, PA · Pittsburgh, PA · +29 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Pittsburgh, PA · +15 more sites
RecruitingPhase 1 / Phase 2NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Sponsor: PMV Pharmaceuticals, Inc
Philadelphia, PA · Pittsburgh, PA · York, PA · +29 more sites
RecruitingNot applicableNCT07059884
Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
Butler, PA · Indiana, PA · New Castle, PA · +20 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
Hershey, PA · Philadelphia, PA · Pittsburgh, PA · +43 more sites
RecruitingPhase 3NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sponsor: Janssen Research & Development, LLC
Bala-Cynwyd, PA · Lancaster, PA · Philadelphia, PA · +51 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Allentown, PA · Bala-Cynwyd, PA · Hershey, PA · +56 more sites
RecruitingPhase 1NCT07493512
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Philadelphia, PA · Pittsburgh, PA · +10 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
Philadelphia, PA · Pittsburgh, PA · +23 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Altoona, PA · Beaver, PA · Broomall, PA · +338 more sites
RecruitingPhase 1NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Sponsor: Orano Med Theranostics, SAS
Pittsburgh, PA · +7 more sites
RecruitingPhase not listedNCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Sponsor: UMC Utrecht
Pittsburgh, PA · +2 more sites
RecruitingPhase not listedNCT07222436
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Sponsor: University of Pittsburgh
Pittsburgh, PA
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Philadelphia, PA · Pittsburgh, PA · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.